Lycurim was used in the therapy of 41 CLL patients, in 34 a positive clinical effect was found. The effect was marked in cases of CLL associated with autoimmune haemolytic anaemia. The immunodepressive property of Lycurim was confirmed by immunological investigation. It has been shown that the levels of IgG, IgA and IgM fall after Lycurim treatment of CLL patients. At the same time the T-lymphocyte count decreases and a tendency for EAC rosette-forming B-lymphocyte decrease is marked.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
cll patients
8
lycurim
4
lycurim r-74
4
r-74 therapy
4
therapy chronic
4
chronic lymphocytic
4
lymphocytic leukaemia
4
leukaemia lycurim
4
lycurim therapy
4
therapy cll
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!